US Patent Issued to Ionis Pharmaceuticals on March 24 for "Compositions for modulating Ataxin 2 expression" (California Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,128, issued on March 24, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.).

"Compositions for modulating Ataxin 2 expression" was invented by Susan M. Freier (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are antisense compounds and methods for decreasing Ataxin 2 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate Ataxin 2 associated diseases, disorders, and conditions. Such Ataxin 2 associated diseases include spinocerebellar ataxia type 2 (SCA2), amyotropic sclerosis (ALS), and parkinsonism."

The patent was filed on Oct. 24, 2023, under Applic...